Anthropology, Cultural
|
D000884 |
[Study of social phenomena which characterize the learned, shared, and transmitted social activities of particular ethnic groups with focus on the causes, consequences, and complexities of human social and cultural variability.
, Study of objects made or used by people, especially the folk artifacts produced by traditional methods, as well as techniques of their production.
] |
Anthropology, Medical
|
D060432 |
[Field of social science that is concerned with differences between human groups as related to health status and beliefs.
] |
Anthropology, Physical
|
D000885 |
[The comparative science dealing with the physical characteristics of humans as related to their origin, evolution, and development in the total environment.
] |
Anthropometry
|
D000886 |
[The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
] |
Anthroposophy
|
D000887 |
[Knowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher (1861-1925). (Webster, 3d ed)
] |
Anti-Allergic Agents
|
D018926 |
[Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)
] |
Anti-Anxiety Agents
|
D014151 |
[Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
] |
Anti-Arrhythmia Agents
|
D000889 |
[Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
] |
Anti-Asthmatic Agents
|
D018927 |
[Drugs that are used to treat asthma.
] |
Anti-Bacterial Agents
|
D000900 |
[Substances produced by microorganisms that can inhibit or suppress the growth of other microorganisms.
, Substances that inhibit the growth or reproduction of BACTERIA.
, Substances that kill BACTERIA.
] |
Anti-Citrullinated Protein Antibodies
|
D000075422 |
[Autoantibodies to citrullinated-peptides and proteins.
] |
Anti-Dyskinesia Agents
|
D018726 |
[Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
] |
Anti-Glomerular Basement Membrane Disease
|
D019867 |
[An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.
] |
Anti-HIV Agents
|
D019380 |
[Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
] |
Anti-Infective Agents
|
D000890 |
[Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
, Generically, any agent that destroys microbes. However, usage of the term is increasingly being confined to agents that prevent or reduce the transmission of SEXUALLY TRANSMITTED DISEASES.
] |
Anti-Infective Agents, Local
|
D000891 |
[Generically, any topical agent that destroys microbes. However, usage of the term is increasingly being confined to topical agents that prevent or reduce the transmission of SEXUALLY TRANSMITTED DISEASES.
, Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.
] |
Anti-Infective Agents, Urinary
|
D000892 |
[Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
] |
Anti-Inflammatory Agents
|
D000893 |
[Substances that reduce or suppress INFLAMMATION.
] |
Anti-Inflammatory Agents, Non-Steroidal
|
D000894 |
[Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
] |
Anti-Mullerian Hormone
|
D054304 |
[A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
] |